Last updated: Fri, Oct 23, 2026, 2:00 PM IST · mainboard IPO · NSE & BSE · Day 3 of 3
- Paras Healthcare IPO subscribed 0.45x overall on Day 3, up from 0.34x on Day 2
- Total bids: 54,84,381 shares against 1,20,83,331 shares on offer
- Category-wise: QIB 0.11x, NII 0.37x, Retail 1.63x
- Price band: ₹660 to ₹693 per share
- The issue closes on Fri, Oct 23, 2026
The Paras Healthcare IPO concludes its third and final day of bidding with an overall subscription multiple of 0.45x as of 2:00 PM IST on October 23, 2026. This represents an increase from the 0.34x subscription multiple recorded at the end of the second day. The retail category remains the most-bid segment, reaching a subscription multiple of 1.63x by the final afternoon.
Paras Healthcare IPO Subscription Status: Day 3
Day-wise subscription
| Day | Date | Total bids (shares) | Bid value at upper band (₹ crore) | Subscribed (x) |
|---|---|---|---|---|
| Day 1 | Wed, Oct 21, 2026 | 17,81,619 | 123.47 | 0.15x |
| Day 2 | Thu, Oct 22, 2026 | 41,24,631 | 285.84 | 0.34x |
| Day 3 | Fri, Oct 23, 2026 | 54,84,381 | 380.07 | 0.45x |
Category-wise subscription
| Category | Shares offered | Day 2 bids | Day 2 (x) | Day 3 bids | Day 3 (x) |
|---|---|---|---|---|---|
| QIB | 65,90,908 | 4,27,560 | 0.06x | 6,98,082 | 0.11x |
| NII | 32,95,454 | 8,27,253 | 0.25x | 12,07,143 | 0.37x |
| of which individual NII | — | 7,76,685 | — | 11,44,227 | — |
| of which corporate NII | — | 35,406 | — | 45,108 | — |
| of which other NII | — | 15,162 | — | 17,808 | — |
| Retail | 21,96,969 | 28,69,818 | 1.31x | 35,79,156 | 1.63x |
| Total | 1,20,83,331 | 41,24,631 | 0.34x | 54,84,381 | 0.45x |
The retail category is the only segment to exceed its quota, reaching 1.63x subscription. In contrast, qualified institutional buyers (QIB) reached 0.11x, while non-institutional investors (NII) reached 0.37x. The total number of bids rose to 54,84,381 shares by the final day, compared to 41,24,631 shares on the second day.
Intraday subscription
| As of | Total bids (shares) | Total (x) | QIB (x) | NII (x) | Retail (x) |
|---|---|---|---|---|---|
| 11:00 AM | 45,42,510 | 0.38x | 0.07x | 0.29x | 1.43x |
| 2:00 PM | 54,84,381 | 0.45x | 0.11x | 0.37x | 1.63x |
Paras Healthcare IPO Offer Details
| Field | Value |
|---|---|
| IPO date | Wed, Oct 21, 2026 to Fri, Oct 23, 2026 |
| Listing date | To be announced |
| Face value | ₹1 per share |
| Price band | ₹660 to ₹693 per share |
| Lot size | 21 shares |
| Total issue size | 1,20,83,331 shares (₹837 crore) |
| Listing at | NSE & BSE |
| Lead managers | JM Financial Ltd., BofA Securities India Ltd., Nuvama Wealth Management Ltd. |
| Registrar | MUFG Intime India Pvt Ltd. |
About Paras Healthcare
Paras Healthcare Ltd. is a clinical specialty-led hospital platform providing tertiary and quaternary healthcare services. As per the DRHP, the company operates a network of eight hospitals under the Paras Health brand with an aggregate bed capacity of 2,211 beds as of June 30, 2026. Its operations span North India, Bihar, and Jharkhand. The company serves self-pay patients, insurance providers, and government schemes. It focuses on providing specialized medical care in Tier 2 and 3 cities, offering services such as cardiac sciences, oncology, and neuro sciences across its hospital network.
Paras Healthcare Financial Highlights
| Metric | FY 2025-26 | FY 2024-25 | FY 2023-24 |
|---|---|---|---|
| Revenue from operations (₹ crore) | 1,605.95 | 1,294.06 | 1,129.04 |
| Total income (₹ crore) | 1,628.78 | 1,314.21 | 1,164.41 |
| Profit after tax (₹ crore) | 43.83 | -57.98 | -15.33 |
| Net worth (₹ crore) | 394.94 | 280.49 | 338.51 |
| Total borrowings (₹ crore) | 323.43 | 227.55 | 148.38 |
| EPS (₹) | 4.34 | -5.94 | -1.57 |
Revenue from operations grew from ₹1,294.06 crore in FY 2024-25 to ₹1,605.95 crore in FY 2025-26. Profit after tax shifted from a loss of ₹57.98 crore in FY 2024-25 to a profit of ₹43.83 crore in FY 2025-26. Total borrowings increased to ₹323.43 crore in FY 2025-26.
Objects of the Issue
| Purpose | Amount (₹ crore) |
|---|---|
| Prepayment or scheduled re-payment of a portion of certain outstanding borrowings availed by our Com | 320.90 |
| Investment in our wholly owned Subsidiary, PMHPL (which also operates our hospital in Srinagar) | 54.10 |
Risk Factors as per the DRHP
- The company faces various outstanding legal proceedings against the entity, its subsidiaries, promoter, and directors, which could impact its financial condition.
- Operations rely on third-party suppliers, with the top 10 suppliers accounting for a significant portion of the company’s total supplies and equipment.
- The healthcare industry is highly regulated and subject to pricing norms, which may change and impact the company’s ability to pass on increased costs due to inflation.
How to Check Paras Healthcare IPO Subscription Status
Live bidding figures are published by NSE & BSE while the issue is open. Once it closes, allotment status is published by the registrar, MUFG Intime India Pvt Ltd. (https://in.mpms.mufg.com/).
This article is for information only and is not investment advice. Subscription figures are based on exchange data as of Fri, Oct 23, 2026, 2:00 PM IST and can change. IPO investments are subject to market risks; read the offer document carefully before investing.